A. Mitra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
A. Mitra has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
A. Boon
Histopathology, St James's University Hospital, Leeds, U.K.
1 shared publicationA. Sillitoe
Departments of Dermatology, Plastic Surgery
1 shared publicationA. Yung
Leeds General Infirmary, Dermatology, Leeds, UK E‐mail
1 shared publicationB. Pollock
Departments of Dermatology, Immunology
1 shared publicationC. L. Wilson
Leeds General Infirmary, Dermatology, Leeds, UK
1 shared publicationJ. Gooi
Departments of Dermatology, Immunology
1 shared publication
Latest Publications
- 1 May 2006
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 31 (3) , 483-484
An asymptomatic pink plaque on the cheek
- 1 May 2006
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 31 (3) , 483-484
An asymptomatic pink plaque on the cheek
- 1 March 2006
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 31 (2) , 298-299
Lentiginous hyperpigmentation confined to resolved psoriatic plaques and treated with a Q-switched ruby laser
- 1 March 2006
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 31 (2) , 298-299
Lentiginous hyperpigmentation confined to resolved psoriatic plaques and treated with a Q-switched ruby laser
- 8 February 2006
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 31 (2) , 299-300
A trial of low-dose UVA1 phototherapy for two patients with recalcitrant discoid lupus erythematosus
- 8 February 2006
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 31 (2) , 299-300
A trial of low-dose UVA1 phototherapy for two patients with recalcitrant discoid lupus erythematosus
- 5 July 2005
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 153 (1) , 194-199
Cutaneous granulomas associated with primary immunodeficiency disorders
Cutaneous granulomas are uncommon in primary immunodeficiency disorders. We report cutaneous granulomas in a child with ataxia telangiectasia (AT) and compare the clinical course with similar lesions in an adult with common variable immunodeficiency (CVI). A 4‐year‐old female with AT developed cutaneous granulomas as erythematous plaques. The largest lesion appeared on her left cheek and continued to progress despite treatment with topical and intralesional steroids. Disease control was obtained initially with oral antibiotics and low‐dose oral steroids. On cessation of oral steroids, significant relapse of the facial granuloma occurred. Pulsed and then oral steroids were required to stop the disease process leaving significant scarring. The second case is of cutaneous granulomas in a 66‐year‐old man, with CVI, who presented with an erythematous reticulate rash on the legs. We consider it useful to report this patient here as disease control was obtained in a similar way with systemic immunosuppression. In this patient a combination of oral steroids and azathioprine was used. These cutaneous granulomas are thought to be a manifestation of immune dysregulation. No infectious cause has been found so far. We recommend the use of broad‐spectrum antibiotics in conjunction with systemic steroids for progressive granulomas, as these patients are immunosuppressed and infection with an unidentified organism cannot be excluded.
- 5 July 2005
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 153 (1) , 194-199
Cutaneous granulomas associated with primary immunodeficiency disorders
Cutaneous granulomas are uncommon in primary immunodeficiency disorders. We report cutaneous granulomas in a child with ataxia telangiectasia (AT) and compare the clinical course with similar lesions in an adult with common variable immunodeficiency (CVI). A 4‐year‐old female with AT developed cutaneous granulomas as erythematous plaques. The largest lesion appeared on her left cheek and continued to progress despite treatment with topical and intralesional steroids. Disease control was obtained initially with oral antibiotics and low‐dose oral steroids. On cessation of oral steroids, significant relapse of the facial granuloma occurred. Pulsed and then oral steroids were required to stop the disease process leaving significant scarring. The second case is of cutaneous granulomas in a 66‐year‐old man, with CVI, who presented with an erythematous reticulate rash on the legs. We consider it useful to report this patient here as disease control was obtained in a similar way with systemic immunosuppression. In this patient a combination of oral steroids and azathioprine was used. These cutaneous granulomas are thought to be a manifestation of immune dysregulation. No infectious cause has been found so far. We recommend the use of broad‐spectrum antibiotics in conjunction with systemic steroids for progressive granulomas, as these patients are immunosuppressed and infection with an unidentified organism cannot be excluded.